Literature DB >> 16333460

Darbepoetin alfa (Aranesp).

John Powell1, Cheryle Gurk-Turner.   

Abstract

Year:  2002        PMID： 16333460      PMCID： PMC1276633          DOI： 10.1080/08998280.2002.11927861

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  10 in total

1.  IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000.

Authors: 
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

2.  Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients.

Authors:  I C Macdougall; S J Gray; O Elston; C Breen; B Jenkins; J Browne; J Egrie
Journal:  J Am Soc Nephrol       Date:  1999-11       Impact factor: 10.121

3.  Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency.

Authors:  F Locatelli; J Olivares; R Walker; M Wilkie; B Jenkins; C Dewey; S J Gray
Journal:  Kidney Int       Date:  2001-08       Impact factor: 10.612

Review 4.  Novel erythropoiesis stimulating protein.

Authors:  I C Macdougall
Journal:  Semin Nephrol       Date:  2000-07       Impact factor: 5.299

Review 5.  Chemotherapy-induced anemia in adults: incidence and treatment.

Authors:  J E Groopman; L M Itri
Journal:  J Natl Cancer Inst       Date:  1999-10-06       Impact factor: 13.506

6.  Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: any evidence of erythropoietin resistance?

Authors:  D N Cruz; M A Perazella; A K Abu-Alfa; R L Mahnensmith
Journal:  Am J Kidney Dis       Date:  1996-10       Impact factor: 8.860

7.  A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy.

Authors:  J Glaspy; J S Jadeja; G Justice; J Kessler; D Richards; L Schwartzberg; J Rigas; D Kuter; D Harmon; D Prow; G Demetri; D Gordon; J Arseneau; A Saven; H Hynes; R Boccia; J O'Byrne; A B Colowick
Journal:  Br J Cancer       Date:  2001-04       Impact factor: 7.640

8.  Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer.

Authors:  R E Smith; I A Jaiyesimi; L A Meza; N S Tchekmedyian; D Chan; H Griffith; S Brosman; R Bukowski; M Murdoch; M Rarick; A Saven; A B Colowick; A Fleishman; U Gayko; J Glaspy
Journal:  Br J Cancer       Date:  2001-04       Impact factor: 7.640

9.  Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: preliminary report.

Authors:  A C Heatherington; J Schuller; A J Mercer
Journal:  Br J Cancer       Date:  2001-04       Impact factor: 7.640

Review 10.  Development and characterization of novel erythropoiesis stimulating protein (NESP).

Authors:  J C Egrie; J K Browne
Journal:  Br J Cancer       Date:  2001-04       Impact factor: 7.640
  10 in total
  6 in total

Review 1.  Erythropoietin in Optic Neuropathies: Current Future Strategies for Optic Nerve Protection and Repair.

Authors:  Yi-Fen Lai; Ting-Yi Lin; Pin-Kuan Ho; Yi-Hao Chen; Yu-Chuan Huang; Da-Wen Lu
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

2.  Recent developments in protein and peptide parenteral delivery approaches.

Authors:  Ashaben Patel; Kishore Cholkar; Ashim K Mitra
Journal:  Ther Deliv       Date:  2014-03

3.  Cytokine combination therapy with erythropoietin and granulocyte colony stimulating factor in a porcine model of acute myocardial infarction.

Authors:  Franca S Angeli; Nicolas Amabile; Mia Shapiro; Rachel Mirsky; Lauren Bartlett; Yan Zhang; Renu Virmani; Kanu Chatterjee; Andrew Boyle; William Grossman; Yerem Yeghiazarians
Journal:  Cardiovasc Drugs Ther       Date:  2010-12       Impact factor: 3.727

4.  Erythropoietin use and abuse.

Authors:  M Joseph John; Vineeth Jaison; Kunal Jain; Naveen Kakkar; Jubbin J Jacob
Journal:  Indian J Endocrinol Metab       Date:  2012-03

5.  Guidelines on the treatment of anemia of chronic renal failure using recombinant human erythropoietin: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2014.

Authors:  Aderson da Silva Araújo; Clarisse Lopes de Castro Lobo; Dimas Tadeu Covas; Fernando Ferreira Costa; Letícia Medeiros; Rodolfo Delfini Cançado; Sandra Fátima Menosi Gualandro; Sara Teresinha Olalla Saad
Journal:  Rev Bras Hematol Hemoter       Date:  2014-10-01

6.  Comparison of Pharmacokinetic, Pharmacodynamic and Tolerability Profiles of CKD-11101, Darbepoetin Alfa (NESP®) Biosimilar, to Those of NESP® After a Single Subcutaneous or Intravenous Administration to Healthy Subjects.

Authors:  Inseung Jeon; Jaeseong Oh; Yu-Kyung Kwon; Seo Hyun Yoon; Joo-Youn Cho; In-Jin Jang; Kyung-Sang Yu; SeungHwan Lee
Journal:  Drug Des Devel Ther       Date:  2021-04-28       Impact factor: 4.162
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.